It's a case study based on an active area of innovation, antibiotic sensitivity testing. However, I'd emphasize the the scope and logic of the thinking applies to other kinds of diagnostics (or even other kinds of medical innovation) as well.
Wednesday, October 31, 2018
Consortium Paper Sets High Water Mark for a Diagnostics Strategic Landscape (Case Study: AST)
A new paper in Nature Reviews Microbiology sets a high standard for thinking about the dynamics and strategies of commercialization of a class of novel diagnostics.
It's a case study based on an active area of innovation, antibiotic sensitivity testing. However, I'd emphasize the the scope and logic of the thinking applies to other kinds of diagnostics (or even other kinds of medical innovation) as well.
It's a case study based on an active area of innovation, antibiotic sensitivity testing. However, I'd emphasize the the scope and logic of the thinking applies to other kinds of diagnostics (or even other kinds of medical innovation) as well.
